跳至主要内容
临床试验/NCT05321745
NCT05321745招募中不适用

Repeated and Periodic Fecal Microbiota Transplantation in Children With Active and Refractory Crohn's Disease

Biao Zou1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年3月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Clinical remission

研究概览

简要总结

This study will test the safety and effectiveness of fecal microbiota transplantation (FMT) plus partial enteral nutrition (PEN) in refractory pediatric Crohn's disease (CD) who have failed conventional treatment

详细描述

Recent studies have suggested that gut imbalance and deregulation of immunological responses plays a pivotal role in the disease development of Crohn's disease (CD), and that FMT could be a useful treatment. Our study is aims to repeated and multiple FMTs plus PEN in the treatment of refractory pediatric CD. In the induction stage of CD, standard therapy remained unchanged, FMT and PEN were added, and FMT was given 1-2 courses, 3-6 times per course. In the maintaining stage, FMT was performed every 3 months, with the same 3-6 times of FMT treatment for each course, and the withdrawal of conventional drug therapy was gradually reduced. Refractory CD was defined as refractory to standard therapy (e.g., steroids, immunomodulators, cyclosporine, tacrolimus, or anti-TNF agents).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged 2-16 years and without genetic diseases; All refractory pediatric with mild-to-moderate CD; Mild-to-moderate CD, defined by the pediatric Crohn's disease activity index (PCDAI) >10 and ≤40 and Simple Endoscopic Score for CD (SES-CD) > 3 were enrolled in the study; refractory CD, defined by children who failed conventional treatment (hormone, immunosuppressant, biologics)

排除标准

  • Children who were treated by PEN (80%) less than 8 weeks; follow up less than 3 months; known contraindication to all FMT infusion method such as nasoduodenal tube insertion, oesophago-gastro-duodenoscopy (OGD), enteroscopy, colonoscopy, enema and Fecal capsule; unwilling to give informed consent/assent

研究组 & 干预措施

Repeated and multiple FMTs plus PEN

Experimental

repeated and multiple FMTs plus PEN(50% of total calories as polymeric diet, Peptamen, Nestle, Vevey, Switzerland) in refractory pediatric CD

干预措施: Standardized FMT (Other)

结局指标

主要结局

Clinical remission

时间窗: 8-12 weeks after FMT

Clinical remission defined as a Pediatric Crohn's Disease Activity Index (PCDAI) score≤10

Endoscopic remission

时间窗: 8-12 weeks after FMT

Endoscopic remission defined by a Simple Endoscopic Score for CD (SES-CD) ≤ 2

Mucosal healing

时间窗: 8-12 weeks after FMT

Mucosal healing defined as SES-CD = 0

次要结局

  • Adverse events(2 and 8 weeks after FMT)

研究者

发起方
Biao Zou
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Biao Zou

attending physician

Tongji Hospital

研究点 (1)

Loading locations...

相似试验